{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T14:09:14Z","timestamp":1758809354402,"version":"3.38.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China Major Research Program Cultivation Project","award":["91949113"],"award-info":[{"award-number":["91949113"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Poor ovarian response (POR) is a challenging condition in assisted reproduction technology. Oral contraceptives (OCs) are commonly used to suppress gonadotropin hormone release in POR patients to synchronize the development of antral follicles before ovarian stimulation. Nevertheless, the question of whether such approach confers advantageous outcomes has elicited inconclusive results in previous studies. Therefore, the objective of this study was to investigate the effect of OCs pretreatment in low prognosis patients stratified by Patient-Oriented Strategies Encompassing Individualized Oocyte Number (POSEIDON) criteria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This retrospective cohort study included 2,222 patients undergoing their first IVF or ICSI cycle from January 2012 to April 2022. After propensity score matching, 369 patients were in the OC pretreatment group and 879 in the control group. Patients were divided into four subgroups based on the POSEIDON criteria. Comparisons of ovarian response and clinical outcomes were conducted, and multivariable logistic regression was used to assess the association between OCs pretreatment and live birth, clinical pregnancy, and pregnancy loss rates.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Patients in POSEIDON group 1 who received OCs pretreatment exhibited a significant reduction in the dose and duration of gonadotropin administration, along with an increase in the number of oocytes retrieved, 2 pronuclei, available embryos, and good quality embryos, indicating an improvement in their ovarian response to exogenous gonadotropins. Additionally, the live birth rate (<jats:italic>P<\/jats:italic>\u2009=\u20090.030) and clinical pregnancy rate (<jats:italic>P<\/jats:italic>\u2009=\u20090.012) were significantly higher in the OCs pretreatment group. Multivariate logistic regression analysis demonstrated a positive association between OCs pretreatment and live birth rate (<jats:italic>P<\/jats:italic>\u2009=\u20090.008) and clinical pregnancy rate (<jats:italic>P<\/jats:italic>\u2009=\u20090.008). However, in POSEIDON group 2 to group 4, there were no significant differences in ovarian response or clinical outcomes between the OCs pretreatment group and the control group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Administering OCs as pretreatment prior to ovarian stimulation using gonadotrophin releasing hormone antagonist protocol appears to be a more favorable approach than waiting for natural menses in low prognosis patients belonging to POSEIDON group 1.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13048-025-01613-6","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:21:25Z","timestamp":1741350085000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pretreatment with oral contraceptives benefit POSEIDON group 1 low prognosis patients during GnRH-antagonist protocol: a propensity score-matched retrospective cohort study"],"prefix":"10.1186","volume":"18","author":[{"given":"Ning","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"key":"1613_CR1","doi-asserted-by":"crossref","unstructured":"Abu-Musa A, Haahr T. Novel physiology and definition of poor ovarian response. Clin Recommendations. 2020;21(6).","DOI":"10.3390\/ijms21062110"},{"key":"1613_CR2","doi-asserted-by":"crossref","unstructured":"Giannelou P, Simopoulou M. The Conundrum of Poor Ovarian Response: From Diagnosis to Treatment. 2020;10(9).","DOI":"10.3390\/diagnostics10090687"},{"issue":"7","key":"1613_CR3","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","volume":"26","author":"AP Ferraretti","year":"2011","unstructured":"Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L. ESHRE consensus on the definition of \u2018poor response\u2019 to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26(7):1616\u201324.","journal-title":"Hum Reprod"},{"issue":"6","key":"1613_CR4","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.fertnstert.2016.02.005","volume":"105","author":"C Alviggi","year":"2016","unstructured":"Alviggi C, Andersen CY, Buehler K, Conforti A, De Placido G, Esteves SC, et al. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril. 2016;105(6):1452\u20133.","journal-title":"Fertil Steril"},{"issue":"4","key":"1613_CR5","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.fertnstert.2022.02.026","volume":"117","author":"MI Cedars","year":"2022","unstructured":"Cedars MI. Managing poor ovarian response in the patient with diminished ovarian reserve. Fertil Steril. 2022;117(4):655\u20136.","journal-title":"Fertil Steril"},{"key":"1613_CR6","first-page":"29","volume-title":"Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial","author":"Y Xu","year":"2018","unstructured":"Xu Y, Nisenblat V, Lu C, Li R, Qiao J, Zhen X, et al. Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial. Volume 16. Reproductive biology and endocrinology: RB&E; 2018. p. 29. 1."},{"issue":"1","key":"1613_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12958-018-0342-1","volume":"16","author":"T Haahr","year":"2018","unstructured":"Haahr T, Esteves SC, Humaidan P. Individualized controlled ovarian stimulation in expected poor-responders: an update. Reproductive Biology Endocrinology: RB&E. 2018;16(1):20.","journal-title":"Reproductive Biology Endocrinology: RB&E"},{"issue":"5","key":"1613_CR8","first-page":"Cd006109","volume":"5","author":"C Farquhar","year":"2017","unstructured":"Farquhar C, Rombauts L, Kremer JA, Lethaby A, Ayeleke RO. Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques. Cochrane Database Syst Rev. 2017;5(5):Cd006109.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"1613_CR9","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.fertnstert.2016.09.013","volume":"106","author":"J Nassar","year":"2016","unstructured":"Nassar J, Tadros T, Adda-Herzog E, Ayoubi JM, Fanchin R. Steroid hormone pretreatments in assisted reproductive technology. Fertil Steril. 2016;106(7):1608\u201314.","journal-title":"Fertil Steril"},{"issue":"3","key":"1613_CR10","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1080\/13697137.2018.1439912","volume":"21","author":"M Chen","year":"2018","unstructured":"Chen M, Han H, Chuai Y, Hao M, Shu M, Shang W. Effects of oral contraceptives on ovulation induction in in vitro fertilization patients with premature ovarian insufficiency. Climacteric: J Int Menopause Soc. 2018;21(3):276\u20139.","journal-title":"Climacteric: J Int Menopause Soc"},{"issue":"9","key":"1613_CR11","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/BF02066431","volume":"13","author":"SR Lindheim","year":"1996","unstructured":"Lindheim SR, Barad DH, Witt B, Ditkoff E, Sauer MV. Short-term gonadotropin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation. J Assist Reprod Genet. 1996;13(9):745\u20137.","journal-title":"J Assist Reprod Genet"},{"issue":"1","key":"1613_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0015-0282(97)81862-6","volume":"67","author":"W Schoolcraft","year":"1997","unstructured":"Schoolcraft W, Schlenker T, Gee M, Stevens J, Wagley L. Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol. Fertil Steril. 1997;67(1):93\u20137.","journal-title":"Fertil Steril"},{"issue":"5","key":"1613_CR13","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1016\/j.fertnstert.2009.05.013","volume":"92","author":"CH Kim","year":"2009","unstructured":"Kim CH, Jeon GH, Cheon YP, Jeon I, Kim SH, Chae HD, et al. Comparison of GnRH antagonist protocol with or without oral contraceptive pill pretreatment and GnRH agonist low-dose long protocol in low responders undergoing IVF\/intracytoplasmic sperm injection. Fertil Steril. 2009;92(5):1758\u201360.","journal-title":"Fertil Steril"},{"key":"1613_CR14","unstructured":"al-Mizyen E, Sabatini L, Lower AM, Wilson CM, al-Shawaf T, Grudzinskas JG. Does pretreatment with progestogen or oral contraceptive pills in low responders followed by the GnRHa flare protocol improve the outcome of IVF-ET? J Assist Reprod Genet. 2;17(3):140\u20136."},{"issue":"2","key":"1613_CR15","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/humrep\/dew325","volume":"32","author":"D Wei","year":"2017","unstructured":"Wei D, Shi Y, Li J, Wang Z, Zhang L, Sun Y, et al. Effect of pretreatment with oral contraceptives and progestins on IVF outcomes in women with polycystic ovary syndrome. Hum Reprod. 2017;32(2):354\u201361.","journal-title":"Hum Reprod"},{"issue":"4","key":"1613_CR16","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.fertnstert.2020.05.021","volume":"114","author":"Y Lu","year":"2020","unstructured":"Lu Y, Wang Y, Zhang T, Wang G, He Y, Lindheim SR, et al. Effect of pretreatment oral contraceptives on fresh and cumulative live birth in vitro fertilization outcomes in ovulatory women. Fertil Steril. 2020;114(4):779\u201386.","journal-title":"Fertil Steril"},{"issue":"6","key":"1613_CR17","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/ejcts\/ezy167","volume":"53","author":"U Benedetto","year":"2018","unstructured":"Benedetto U, Head SJ, Angelini GD, Blackstone EH. Statistical primer: propensity score matching and its alternatives. Eur J Cardiothorac Surg. 2018;53(6):1112\u20137.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1613_CR18","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1146\/annurev.psych.58.110405.085530","volume":"60","author":"JW Graham","year":"2009","unstructured":"Graham JW. Missing data analysis: making it work in the real world. Annu Rev Psychol. 2009;60:549\u201376.","journal-title":"Annu Rev Psychol"},{"key":"1613_CR19","unstructured":"The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod. 2011;26(6):1270-83."},{"issue":"1","key":"1613_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13048-019-0522-4","volume":"12","author":"C Bessow","year":"2019","unstructured":"Bessow C, Donato R, de Souza T, Chapon R, Genro V, Cunha-Filho JS. Antral follicle responsiveness assessed by follicular output RaTe(FORT) correlates with follicles diameter. J Ovarian Res. 2019;12(1):48.","journal-title":"J Ovarian Res"},{"issue":"5","key":"1613_CR21","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.fertnstert.2013.06.049","volume":"100","author":"M Huber","year":"2013","unstructured":"Huber M, Hadziosmanovic N, Berglund L, Holte J. Using the ovarian sensitivity index to define poor, normal, and high response after controlled ovarian hyperstimulation in the long gonadotropin-releasing hormone-agonist protocol: suggestions for a new principle to solve an old problem. Fertil Steril. 2013;100(5):1270\u20136.","journal-title":"Fertil Steril"},{"issue":"2","key":"1613_CR22","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S0015-0282(02)04574-0","volume":"79","author":"R Fanchin","year":"2003","unstructured":"Fanchin R, Cunha-Filho JS, Schon\u00e4uer LM, Kadoch IJ, Cohen-Bacri P, Frydman R. Coordination of early antral follicles by luteal estradiol administration provides a basis for alternative controlled ovarian hyperstimulation regimens. Fertil Steril. 2003;79(2):316\u201321.","journal-title":"Fertil Steril"},{"issue":"12","key":"1613_CR23","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1093\/humrep\/deg516","volume":"18","author":"R Fanchin","year":"2003","unstructured":"Fanchin R, Salomon L, Castelo-Branco A, Olivennes F, Frydman N, Frydman R. Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists. Hum Reprod. 2003;18(12):2698\u2013703.","journal-title":"Hum Reprod"},{"issue":"6","key":"1613_CR24","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1210\/jcem-64-6-1109","volume":"64","author":"V Mais","year":"1987","unstructured":"Mais V, Cetel NS, Muse KN, Quigley ME, Reid RL, Yen SS. Hormonal dynamics during luteal-follicular transition. J Clin Endocrinol Metab. 1987;64(6):1109\u201314.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1613_CR25","first-page":"1038","volume":"81","author":"NA Klein","year":"1996","unstructured":"Klein NA, Battaglia DE, Fujimoto VY, Davis GS, Bremner WJ, Soules MR. Reproductive aging: accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women. J Clin Endocrinol Metab. 1996;81(3):1038\u201345.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1613_CR26","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/0010-7824(79)90053-2","volume":"20","author":"BL Cohen","year":"1979","unstructured":"Cohen BL, Katz M. Pituitary and ovarian function in women receiving hormonal contraception. Contraception. 1979;20(5):475\u201387.","journal-title":"Contraception"},{"issue":"2","key":"1613_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1472-6483(10)60621-9","volume":"13","author":"JA Huirne","year":"2006","unstructured":"Huirne JA, van Loenen AC, Donnez J, Pirard C, Homburg R, Schats R, et al. Effect of an oral contraceptive pill on follicular development in IVF\/ICSI patients receiving a GnRH antagonist: a randomized study. Reprod Biomed Online. 2006;13(2):235\u201345.","journal-title":"Reprod Biomed Online"},{"issue":"8","key":"1613_CR28","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1177\/1933719116630419","volume":"23","author":"C Alviggi","year":"2016","unstructured":"Alviggi C, Conforti A, Caprio F, Gizzo S, Noventa M, Strina I, et al. In estimated good prognosis patients could unexpected hyporesponse to controlled ovarian stimulation be related to genetic polymorphisms of FSH receptor? Reprod Sci. 2016;23(8):1103\u20138.","journal-title":"Reprod Sci"},{"issue":"9","key":"1613_CR29","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s10815-012-9812-0","volume":"29","author":"C Schmitz","year":"2012","unstructured":"Schmitz C, Bocca S, Beydoun H, Stadtmauer L, Oehninger S. Does the degree of hypothalamic-pituitary-ovarian recovery after oral contraceptive pills affect outcomes of IVF\/ICSI cycles receiving GnRH-antagonist adjuvant therapy in women over 35 years of age? J Assist Reprod Genet. 2012;29(9):877\u201382.","journal-title":"J Assist Reprod Genet"},{"issue":"6","key":"1613_CR30","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/S0015-0282(99)00146-6","volume":"71","author":"C Fitzgerald","year":"1999","unstructured":"Fitzgerald C, Elstein M, Spona J. Effect of age on the response of the hypothalamo-pituitary-ovarian axis to a combined oral contraceptive. Fertil Steril. 1999;71(6):1079\u201384.","journal-title":"Fertil Steril"},{"issue":"6","key":"1613_CR31","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1016\/j.fertnstert.2010.04.025","volume":"94","author":"G Griesinger","year":"2010","unstructured":"Griesinger G, Kolibianakis EM, Venetis C, Diedrich K, Tarlatzis B. Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis. Fertil Steril. 2010;94(6):2382\u20134.","journal-title":"Fertil Steril"},{"issue":"2","key":"1613_CR32","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1080\/09513590.2018.1500535","volume":"35","author":"Z Xu","year":"2019","unstructured":"Xu Z, Meng L, Pan C, Chen X, Huang X, Yang H. Does oral contraceptives pretreatment affect the pregnancy outcome in polycystic ovary syndrome women undergoing ART with GnRH agonist protocol? Gynecol Endocrinol. 2019;35(2):124\u20137.","journal-title":"Gynecol Endocrinol"},{"key":"1613_CR33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1477-7827-11-54","volume":"11","author":"C Decanter","year":"2013","unstructured":"Decanter C, Robin G, Thomas P, Leroy M, Lefebvre C, Soudan B, et al. First intention IVF protocol for polycystic ovaries: does oral contraceptive pill pretreatment influence COH outcome? Reprod Biol Endocrinol. 2013;11:54.","journal-title":"Reprod Biol Endocrinol"},{"issue":"4","key":"1613_CR34","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/humrep\/deg177","volume":"18","author":"M Creus","year":"2003","unstructured":"Creus M, Ordi J, F\u00e1bregues F, Casamitjana R, Carmona F, Cardesa A, et al. The effect of different hormone therapies on integrin expression and pinopode formation in the human endometrium: a controlled study. Hum Reprod. 2003;18(4):683\u201393.","journal-title":"Hum Reprod"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01613-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01613-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01613-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:21:31Z","timestamp":1741350091000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-025-01613-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1613"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01613-6","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]},"assertion":[{"value":"7 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Peking University First Hospital (approval number: 2020\u2009\u2212\u2009184). The requirement for informed consent was waived by the ethics committee due to the retrospective nature of the study and the use of anonymous data. Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}